Adamas

MannKind Announces CFO Transition

Retrieved on: 
Tuesday, March 26, 2024
Castagna, Professional corporation, KPMG, Information technology, CFO, Business, MannKind Corporation, Patient, Accounting, Adamas, MBA, Investment, KPMG LLP, Retirement, Loyola Marymount University, Deleveraging, CPA, Management

Mr. Binder plans to remain at MannKind through the end of the year as Executive Vice President, Special Projects.

Key Points: 
  • Mr. Binder plans to remain at MannKind through the end of the year as Executive Vice President, Special Projects.
  • “We are excited to have Chris join us at such a pivotal time as our new CFO,” said Michael Castagna, PharmD., Chief Executive Officer for MannKind Corporation.
  • We are pleased that Steve will remain with MannKind for the rest of 2024, allowing for an optimal transition with Chris.”
    “I look forward to working with Chris and remain totally committed to MannKind’s continued success,” said Steve Binder, Chief Financial Officer.
  • His earlier career also included senior financial roles at InterMune, Inc., Dynavax Technologies Corporation and MannKind.

Adamas One Corp. Announces Establishment of Board of Advisors for Adamas One Technologies

Retrieved on: 
Tuesday, March 26, 2024
Diamond, Mathematics, Nano, Growth, Business, Strategic management, Science, Material, Central Waqf Council, Polymer, Analog Devices, Research, Fairchild Semiconductor, Business development, MRAM, Engineering, Onsemi, Adamas, Diamond Vision, Jerry Maguire, NSF, NASA, Publication, Amphenol, Ceramic, Pennsylvania State University, Advanced technology, Information technology

The Board of Advisors is comprised of esteemed industry experts that will provide strategic guidance as Adamas One Technologies explores various applications for lab-grown diamonds in the semiconductor industry.

Key Points: 
  • The Board of Advisors is comprised of esteemed industry experts that will provide strategic guidance as Adamas One Technologies explores various applications for lab-grown diamonds in the semiconductor industry.
  • The newly appointed members include:
    Jerry McGuire- Mr. McGuire is currently the COO of Adamas One Corp. and the President of Adamas One Technologies.
  • The establishment of the Board of Advisors underscores the company's dedication to staying at the forefront of technological advancements and driving value for its stakeholders.
  • Adamas One Corp. is a registered trademark of Adamas One Corp. in the United States and/or other countries.

Adamas One Corp. Receives Prestigious Award for Best Lab-Grown Manufacturer for 2023

Retrieved on: 
Thursday, March 7, 2024
Adamas, Social responsibility, Growth, Beauty, Gemstone

This recognition highlights Adamas One Corp.'s relentless commitment to pioneering advancements in lab-grown diamonds, both within the jewelry industry and the technology sector.

Key Points: 
  • This recognition highlights Adamas One Corp.'s relentless commitment to pioneering advancements in lab-grown diamonds, both within the jewelry industry and the technology sector.
  • Manufacturing Technology Insights Magazine recognized Adamas One Corp. for its groundbreaking contributions to lab-grown diamond manufacturing, emphasizing the company's focus on quality, sustainability, and social responsibility.
  • As the lab-grown diamond industry continues to experience rapid growth, Adamas One Corp. remains at the forefront, setting new standards for excellence and innovation.
  • Jay Grdina, CEO of Adamas One Corp., expressed his gratitude for the award, stating, "Receiving the award for Best Lab-Grown Manufacturer is a tremendous honor for Adamas One Corp.

Adamas One Corp. Provides Shareholder Update

Retrieved on: 
Sunday, February 25, 2024
Diamond, Originality, Intelligence, Adamas, Marketing, Growth, Jewellery, IP, NexGen, United States national laboratories, Elle, Laser, DTC

Third, leverage the company’s extensive IP and continued R&D efforts to exploit opportunities in new sectors, starting with the technology industry.

Key Points: 
  • Third, leverage the company’s extensive IP and continued R&D efforts to exploit opportunities in new sectors, starting with the technology industry.
  • In addition, we fine-tuned our recipes to increase the color and clarity of our diamonds in preparation for expanded distribution.
  • The new site includes a shopping feature for Business-to-Business (B2B) transactions and provides educational materials to help raise awareness of the value and benefits of Adamas’ lab-grown diamonds for our customers.
  • Our goal is to have minimal to no dilutive effect on our current shareholder base from the funds raised to complete the transactions.

Adamas One Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

Retrieved on: 
Friday, February 23, 2024
Diamond, Originality, Annual report, Adamas, WalletHub, Letter, Jewellery, Security (finance), Cryptocurrency

This notification has no immediate effect on the listing of the Company's common stock on Nasdaq.

Key Points: 
  • This notification has no immediate effect on the listing of the Company's common stock on Nasdaq.
  • However, if the Company fails to timely regain compliance with the Nasdaq Listing Rule, the Company's common stock will be subject to delisting from Nasdaq.
  • Pursuant to the notification, the Company has until March 19, 2024 to file both the 2023 Annual Report and the Q1 2024 Quarterly Report, or to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rule for these delinquent reports.
  • If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel.

BioXcel Therapeutics Strengthens Clinical Development Leadership to Advance Late-Stage Programs

Retrieved on: 
Monday, December 11, 2023
Dexmedetomidine, Cardiology, Agitation, FDA, Roche, Actelion, Reata Pharmaceuticals, GSK, Pfizer, IND, Adamas, Medicine, Physician, University, Mount Sinai School, Schizophrenia, Doctor of Philosophy, MEK, Journal of Clinical Pathology, Intermittent explosive disorder, GSK plc, New product development, Caregiver, EMA, Therapy, Patient, Intelligence, Development, Senior, DSM-IV codes, Bipolar disorder, Sanofi, Royal college, Acquisition, Prostate cancer, Clinical trial, Biogen, Pharmaceutical industry

NEW HAVEN, Conn., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced a key executive promotion and a clinical advisor appointment as part of the Company’s strategic reprioritization focused on the advancement of its late-stage clinical programs and emerging pipeline candidates.

Key Points: 
  • Vincent J. O’Neill, M.D., Senior Vice President and Chief Research & Development Officer of OnkosXcel Therapeutics, has been promoted to Executive Vice President, Chief of Product Development and Medical Officer of BioXcel Therapeutics.
  • Additionally, Rajiv Patni, M.D., has been appointed to the newly created position of Strategic Clinical Advisor to the BioXcel Therapeutics Chief Executive Officer and Board of Directors.
  • Prior to joining BioXcel Therapeutics, Dr. O’Neill held senior leadership roles at several leading global pharmaceutical companies, including Sanofi, Genentech, and GlaxoSmithKline.
  • “I look forward to working with the BioXcel leadership team in continuing to address the unmet medical needs of patients and caregivers and advance the Company’s product-development goals.”

Adamas One Corp. Announces Formation of Adamas Technologies

Retrieved on: 
Thursday, November 9, 2023
Diamond, Originality, ICS, McGuire family, Research, Adamas, Red diamond, Thermal conductivity, WD Lab Grown Diamonds, Jewellery, Chemistry, Gemstone

SCOTTSDALE, Ariz., Nov. 9, 2023 /PRNewswire/ -- Adamas One Corp. (Nasdaq: JEWL) ("Adamas One," "Adamas" or the "Company"), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for technology and other industrial uses, today announced the formation of its new wholly owned subsidiary, Adamas Technologies.

Key Points: 
  • Adamas Technologies will be responsible for research & development, partnerships, and deployment of Lab-Grown Diamond-based solutions for the technology industry.
  • Adamas' patented technology provides a significant opportunity to address increasing demand from the semiconductor sector.
  • "The formation of Adamas Technologies follows our recently announced plans to increase our presence in the semiconductor sector.
  • We want to make sure that Adamas One is always in the forefront of Lab-Grown Diamond utilization across industries.

Adamas One Corp. Announces Formation of Adamas Technologies

Retrieved on: 
Thursday, November 9, 2023
Diamond, Originality, ICS, McGuire family, Research, Adamas, Red diamond, Thermal conductivity, WD Lab Grown Diamonds, Jewellery, Chemistry, Gemstone

SCOTTSDALE, Ariz., Nov. 9, 2023 /PRNewswire/ -- Adamas One Corp. (Nasdaq: JEWL) ("Adamas One," "Adamas" or the "Company"), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for technology and other industrial uses, today announced the formation of its new wholly owned subsidiary, Adamas Technologies.

Key Points: 
  • Adamas Technologies will be responsible for research & development, partnerships, and deployment of Lab-Grown Diamond-based solutions for the technology industry.
  • Adamas' patented technology provides a significant opportunity to address increasing demand from the semiconductor sector.
  • "The formation of Adamas Technologies follows our recently announced plans to increase our presence in the semiconductor sector.
  • We want to make sure that Adamas One is always in the forefront of Lab-Grown Diamond utilization across industries.

Adamas One Joins Webull’s Corporate Connect Service

Retrieved on: 
Tuesday, November 7, 2023
Diamond, Originality, News, Adamas, Jewellery, Webull

SCOTTSDALE, Ariz., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for industrial and technology uses, today announced that it has begun participating on the Webull Corporate Connect Service.

Key Points: 
  • SCOTTSDALE, Ariz., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for industrial and technology uses, today announced that it has begun participating on the Webull Corporate Connect Service.
  • The Adamas One page on the Webull Corporate Connect Service will provide real-time Company updates, important announcements, and other relevant content such as news, earnings reports, investor presentations, marketing materials, industry snapshots and more.
  • “We are excited to join the Webull Corporate Connect Service to generate even stronger transparency and communications with our current shareholders and Webull’s clientele.
  • We feel the new Webull platform will also help in expanding our corporate footprint and in educating a new community with regard to Adamas One, our lab grown diamonds and the industry as a whole,” commented Jay Grdina, Adamas One CEO.

Adamas One Corp Announces Initial Delivery of Lab-Grown Colorless Diamonds

Retrieved on: 
Thursday, November 2, 2023
Diamond, IGI, Jewellery, EGL, GIA, Adamas, Originality, Gemstone

SCOTTSDALE, Ariz., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for industrial uses, announces the initial delivery of colorless diamonds.

Key Points: 
  • SCOTTSDALE, Ariz., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) (“Adamas One,” “Adamas” or the “Company”), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to produce high-quality, single-crystal, Lab-Grown Diamonds for jewelry and diamond materials for industrial uses, announces the initial delivery of colorless diamonds.
  • Adamas One’s extensive internal R&D efforts lead to the successful creation of D, E and F diamonds, which are considered to be colorless as determined by gem grading labs such as GIA, IGI, and EGL.
  • “This successful delivery of high-quality lab-grown colorless diamonds is due to our consistent drive to advance our diamond product offerings.
  • Current industry reports are showing lab-grown diamonds now represent more than 50% of diamond sales in the US,” concluded Mr. Grdina.